The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development.
Open accessAbstract
We have recently cloned the human fms-like tyrosine kinase 4 gene FLT4, whose protein product is related to two vascular endothelial growth factor receptors FLT1 and KDR/FLK1. Here the expression of FLT4 has been analyzed by in situ hybridization during mouse embryogenesis and in adult human tissues. The FLT4 mRNA signals first became detectable in the angioblasts of head mesenchyme, the cardinal vein, and extraembryonally in the allantois of 8.5-day postcoitus (p.c.) embryos. In 12.5-day p.c. embryos, the FLT4 signal decorated developing venous and presumptive lymphatic endothelia, but arterial endothelia were negative. During later stages of development, FLT4 mRNA became restricted to vascular plexuses devoid of red cells, representing developing lymphatic vessels. Only the lymphatic endothelia and some high endothelial venules expressed FLT4 mRNA in adult human tissues. Increased expression occurred in lymphatic sinuses in metastatic lymph nodes and in lymphangioma. Our results suggest that FLT4 is a marker for lymphatic vessels and some high endothelial venules in human adult tissues. They also support the theory on the venous origin of lymphatic vessels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folkman, J., & Klagsbrun, M. (1987) · Science · doi:10.1126/science.2432664 · Cited by 3,491
The fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth Factor
de Vries, C., Escobedo, J. A., Ueno, H., Houck, K., Ferrara, N., & Williams, L. T. (1992) · Science · doi:10.1126/science.1312256 · Cited by 2,016
Millauer, B., Wizigmann-Voos, S., Schnürch, H., Martinez, R., Møller, N. P. H., Risau, W., & Ullrich, A. (1993) · Cell · doi:10.1016/0092-8674(93)90573-9 · Cited by 1,927
Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
Terman, B. I., Dougher-Vermazen, M., Carrion, M. E., Dimitrov, D., Armellino, D. C., Gospodarowicz, D., & Böhlen, P. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)90483-2 · Cited by 1,519
Cattoretti, G., Becker, M. H. G., Key, G., Duchrow, M., Schlüuter, C., Galle, J., & Gerdes, J. (1992) · The Journal of Pathology · doi:10.1002/path.1711680404 · Cited by 1,447
The role of angiogenesis in tumor growth.
Folkman, J. (1992) · PubMed · Cited by 1,259
Klagsbrun, M., & D'Amore, P. A. (1991) · Annual Review of Physiology · doi:10.1146/annurev.ph.53.030191.001245 · Cited by 957
Folkman, J., & Shing, Y. (1992) · PubMed · Cited by 789
Endothelial proliferation in tumours and normal tissues: Continuous labelling studies
Hobson, B., & Denekamp, J. (1984) · British Journal of Cancer · doi:10.1038/bjc.1984.66 · Cited by 565
Nucleotide sequence of a full-length cDNA for mouse cytosketetal β-actin raRNA
ToIcunaga, K., Taniguchi, H., Yoda, K., Shimizu, M., & Salciyama, S. (1986) · Nucleic Acids Research · doi:10.1093/nar/14.6.2829 · Cited by 536
Cited by
The Biology of Vascular Endothelial Growth Factor
Ferrara, N., & Davis-Smyth, T. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0287 · Cited by 4,330
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
Hicklin, D. J., & Ellis, L. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.081 · Cited by 3,007
Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
Fong, G.-H., Rossant, J., Gertsenstein, M., & Breitman, M. L. (1995) · Nature · doi:10.1038/376066a0 · Cited by 2,606
Self-citationInduction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis
Skobe, M., Hawighorst, T., Jackson, D. G., Prevo, R., Janes, L., Velasco, P., Riccardi, L., Alitalo, K., Claffey, K., & Detmar, M. (2001) · Nature Medicine · doi:10.1038/84643 · Cited by 1,733
Self-citationJoukov, V., Pajusola, K., Kaipainen, A., Chilov, D., Lahtinen, I., Kukk, E., Saksela, O., Kalkkinen, N., & Alitalo, K. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00359.x · Cited by 1,672
Self-citationSignal transduction by vascular endothelial growth factor receptors
Koch, S., Tugues, S., Li, X., Gualandi, L., & Claesson-Welsh, L. (2011) · Biochemical Journal · doi:10.1042/bj20110301 · Cited by 1,635
Prox1 Function Is Required for the Development of the Murine Lymphatic System
Wigle, J. T., & Oliver, G. (1999) · Cell · doi:10.1016/s0092-8674(00)81511-1 · Cited by 1,579
Karkkainen, M. J., Haiko, P., Sainio, K., Partanen, J., Taipale, J., Petrova, T. V., Jeltsch, M., Jackson, D. G., Talikka, M., Rauvala, H., et al. (2004) · Nature Immunology · doi:10.1038/ni1013 · Cited by 1,421
Self-citationLymphangiogenesis in development and human disease
Alitalo, K., Tammela, T., & Petrova, T. V. (2005) · Nature · doi:10.1038/nature04480 · Cited by 1,285
Self-citationHyperplasia of Lymphatic Vessels in VEGF-C Transgenic Mice
Jeltsch, M., Kaipainen, A., Joukov, V., Meng, X., Lakso, M., Rauvala, H., Swartz, M., Fukumura, D., Jain, R. K., & Alitalo, K. (1997) · Science · doi:10.1126/science.276.5317.1423 · Cited by 1,283
Self-citationVEGF-D promotes the metastatic spread of tumor cells via the lymphatics
Stacker, S. A., Caesar, C., Baldwin, M. E., Thornton, G. E., Williams, R. A., Prevo, R., Jackson, D. G., Nishikawa, S.-I., Kubo, H., & Achen, M. G. (2001) · Nature Medicine · doi:10.1038/84635 · Cited by 1,246
Achen, M. G., Jeltsch, M., Kukk, E., Mäkinen, T., Vitali, A., Wilks, A. F., Alitalo, K., & Stacker, S. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.2.548 · Cited by 1,205
Self-citationAngiosarcomas Express Mixed Endothelial Phenotypes of Blood and Lymphatic Capillaries
Breiteneder-Geleff, S., Soleiman, A., Kowalski, H., Horvat, R., Amann, G., Kriehuber, E., Diem, K., Weninger, W., Tschachler, E., Alitalo, K., et al. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65285-6 · Cited by 1,090
Self-citationVascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis
Mandriota, S. J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.4.672 · Cited by 978
The splice variants of vascular endothelial growth factor (VEGF) and their receptors
Robinson, C. J., & Stringer, S. E. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.5.853 · Cited by 944
An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype
Wigle, J. T., Harvey, N., Detmar, M., Lagutina, I., Grosveld, G., Gunn, M. D., Jackson, D. G., & Oliver, G. (2002) · The EMBO Journal · doi:10.1093/emboj/21.7.1505 · Cited by 943
Vascular endothelial growth factors and angiogenesis in eye disease
Witmer, A. (2003) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(02)00043-5 · Cited by 927
Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands
Jin, S. C., Homsy, J., Zaidi, S., Lu, Q., Morton, S., DePalma, S. R., Zeng, X., Qi, H., Chang, W., Sierant, M. C., et al. (2017) · Nature Genetics · doi:10.1038/ng.3970 · Cited by 875
“FLT4 LoFs resulted in phenotypes distinct from heterozygous missense mutations in the kinase domain that cause defective lymphatic development 35 .”
Cardiovascular Failure in Mouse Embryos Deficient in VEGF Receptor-3
Dumont, D. J., Jussila, L., Taipale, J., Lymboussaki, A., Mustonen, T., Pajusola, K., Breitman, M., & Alitalo, K. (1998) · Science · doi:10.1126/science.282.5390.946 · Cited by 874
Self-citationMakinen, T. (2001) · The EMBO Journal · doi:10.1093/emboj/20.17.4762 · Cited by 845
Griffioen, A. W., & Molema, G. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01448-0 · Cited by 842
The biology of vascular endothelial growth factors
TAMMELA, T., ENHOLM, B., ALITALO, K., & PAAVONEN, K. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.12.002 · Cited by 838
Self-citationMechanisms of normal and tumor-derived angiogenesis
Papetti, M., & Herman, I. M. (2002) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00389.2001 · Cited by 809
Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation
Tammela, T., Zarkada, G., Wallgard, E., Murtomäki, A., Suchting, S., Wirzenius, M., Waltari, M., Hellström, M., Schomber, T., Peltonen, R., et al. (2008) · Nature · doi:10.1038/nature07083 · Cited by 813
Self-citationVascular endothelial growth factor B, a novel growth factor for endothelial cells.
Olofsson, B., Pajusola, K., Kaipainen, A., von Euler, G., Joukov, V, Saksela, O., Orpana, A., Pettersson, R. F., Alitalo, K., & Eriksson, U. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.6.2576 · Cited by 803
Self-citationVascular Dysmorphogenesis Caused by an Activating Mutation in the Receptor Tyrosine Kinase TIE2
Vikkula, M., Boon, L. M., Iii, K. L. C., Calvert, J. T., Diamonti, A. J., Goumnerov, B., Pasyk, K. A., Marchuk, D. A., Warman, M. L., Cantley, L. C., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81814-0 · Cited by 802
Lymphangiogenesis and cancer metastasis
Stacker, S. A., Achen, M. G., Jussila, L., Baldwin, M. E., & Alitalo, K. (2002) · Nature Reviews Cancer · doi:10.1038/nrc863 · Cited by 797
Self-citationSchoppmann, S. F., Birner, P., Stöckl, J., Kalt, R., Ullrich, R., Caucig, C., Kriehuber, E., Nagy, K., Alitalo, K., & Kerjaschki, D. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64255-1 · Cited by 794
Self-citationMäkinen, T., Jussila, L., Veikkola, T., Karpanen, T., Kettunen, M. I., Pulkkanen, K. J., Kauppinen, R., Jackson, D. G., Kubo, H., Nishikawa, S.-I., et al. (2001) · Nature Medicine · doi:10.1038/84651 · Cited by 777
Self-citationProteolytic processing regulates receptor specificity and activity of VEGF-C
Joukov, V., Sorsa, T., Kumar, V., Jeltsch, M., Claesson-Welsh, L., Cao, Y., Saksela, O., Kalkkinen, N., & Alitalo, K. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3898 · Cited by 773
Self-citationAngiogenic and cell survival functions of Vascular Endothelial Growth Factor (VEGF)
Byrne, A. M., Bouchier-Hayes, D. J., & Harmey, J. H. (2005) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2005.tb00379.x · Cited by 744
VEGFs and receptors involved in angiogenesis versus lymphangiogenesis
Lohela, M., Bry, M., Tammela, T., & Alitalo, K. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.12.012 · Cited by 738
Self-citationThe physiology of the lymphatic system
Swartz, M. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00150-8 · Cited by 737
Molecular mechanisms of lymphangiogenesis in health and disease
Alitalo, K., & Carmeliet, P. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00051-x · Cited by 734
Self-citationKukk, E., Lymboussaki, A., Taira, S., Kaipainen, A., Jeltsch, M., Joukov, V., & Alitalo, K. (1996) · Development · doi:10.1242/dev.122.12.3829 · Cited by 690
Self-citationVascular endothelial growth factor and its receptors
Klagsbrun, M., & A. D'Amore, P. (1996) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(96)00027-5 · Cited by 682
Veikkola, T., Jussila, L., Makinen, T., Karpanen, T., Jeltsch, M., Petrova, T. V., Kubo, H., Thurston, G., McDonald, D. M., Achen, M. G., et al. (2001) · The EMBO Journal · doi:10.1093/emboj/20.6.1223 · Cited by 663
Self-citationMissense mutations interfere with VEGFR-3 signalling in primary lymphoedema
Karkkainen, M. J., Ferrell, R. E., Lawrence, E. C., Kimak, M. A., Levinson, K. L., McTigue, M. A., Alitalo, K., & Finegold, D. N. (2000) · Nature Genetics · doi:10.1038/75997 · Cited by 650
Self-citationPetrova, T. V., Mäkinen, T., Mäkelä, T. P., Saarela, J., Virtanen, I., Ferrell, R. E., Finegold, D. N., Kerjaschki, D., Ylä‐Herttuala, S., & Alitalo, K. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf470 · Cited by 632
Self-citationAbnormal lymphatic vessel development in neuropilin 2 mutant mice
Yuan, L., Moyon, D., Pardanaud, L., Bréant, C., Karkkainen, M. J., Alitalo, K., & Eichmann, A. (2002) · Development · doi:10.1242/dev.129.20.4797 · Cited by 632
Self-citationA model for gene therapy of human hereditary lymphedema
Karkkainen, M. J., Saaristo, A., Jussila, L., Karila, K. A., Lawrence, E. C., Pajusola, K., Bueler, H., Eichmann, A., Kauppinen, R., Kettunen, M. I., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221449198 · Cited by 606
Self-citationVascular endothelial growth factor (VEGF) signaling in tumor progression
Roskoski, R. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.01.006 · Cited by 599
Petrova, T. V., Karpanen, T., Norrmén, C., Mellor, R., Tamakoshi, T., Finegold, D., Ferrell, R., Kerjaschki, D., Mortimer, P., Ylä-Herttuala, S., et al. (2004) · Nature Medicine · doi:10.1038/nm1094 · Cited by 592
Self-citationBinding of Ras to Phosphoinositide 3-Kinase p110α Is Required for Ras- Driven Tumorigenesis in Mice
Gupta, S., Ramjaun, A. R., Haiko, P., Wang, Y., Warne, P. H., Nicke, B., Nye, E., Stamp, G., Alitalo, K., & Downward, J. (2007) · Cell · doi:10.1016/j.cell.2007.03.051 · Cited by 589
Self-citationMechanisms of lymphatic metastasis
Karaman, S., & Detmar, M. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71606 · Cited by 584
Tumour vascularization: sprouting angiogenesis and beyond
Hillen, F., & Griffioen, A. W. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9094-7 · Cited by 583
Vascular endothelial growth factor C induces angiogenesis in vivo
Cao, Y., Linden, P., Farnebo, J., Cao, R., Eriksson, A., Kumar, V., Qi, J.-H., Claesson-Welsh, L., & Alitalo, K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14389 · Cited by 565
Self-citationVEGFR-3 and Its Ligand VEGF-C Are Associated with Angiogenesis in Breast Cancer
Valtola, R., Salven, P., Heikkilä, P., Taipale, J., Joensuu, H., Rehn, M., Pihlajaniemi, T., Weich, H., deWaal, R., & Alitalo, K. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65392-8 · Cited by 541
Self-citationBiology of vascular endothelial growth factors
Roy, H., Bhardwaj, S., & Ylä-Herttuala, S. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.03.087 · Cited by 537
Vascular Endothelial Growth Factor: Molecular and Biological Aspects
Ferrara, N. (1999) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-59953-8_1 · Cited by 533
Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate
Hong, Y., Harvey, N., Noh, Y., Schacht, V., Hirakawa, S., Detmar, M., & Oliver, G. (2002) · Developmental Dynamics · doi:10.1002/dvdy.10163 · Cited by 528
PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis
Cao, R., Björndahl, M. A., Religa, P., Clasper, S., Garvin, S., Galter, D., Meister, B., Ikomi, F., Tritsaris, K., Dissing, S., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.08.034 · Cited by 527
Biomarkers of traumatic injury are transported from brain to blood via the glymphatic system.
Plog, B. A., Dashnaw, M. L., Hitomi, E., Peng, W., Liao, Y., Lou, N., Deane, R., & Nedergaard, M. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.3742-14.2015 · Cited by 525
“Transgenic mice expressing a fusion protein of the lymphatic endothelial cell marker vascular endothelial growth factor receptor 3 and yellow fluorescent protein (VEGFR3-YFP) (Kaipainen et al., 1995; Calvo et al., 2011) confirmed that intracortical OA555 was draining specifically to cervical lymphatic structures (Fig.”
BackgroundInfluentialKriehuber, E., Breiteneder-Geleff, S., Groeger, M., Soleiman, A., Schoppmann, S. F., Stingl, G., Kerjaschki, D., & Maurer, D. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.797 · Cited by 525
He, Y., Kozaki, K.-I., Karpanen, T., Koshikawa, K., Yla-Herttuala, S., Takahashi, T., & Alitalo, K. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.11.819 · Cited by 521
Self-citationVEGFs, receptors and angiogenesis
Veikkola, T., & Alitalo, K. (1999) · Seminars in Cancer Biology · doi:10.1006/scbi.1998.0091 · Cited by 508
Self-citationMulliken, J. B., Fishman, S. J., & Burrows, P. E. (2000) · Current Problems in Surgery · doi:10.1016/s0011-3840(00)80013-1 · Cited by 504
VEGF Receptor Signal Transduction
Matsumoto, T., & Claesson-Welsh, L. (2001) · Science's STKE · doi:10.1126/stke.2001.112.re21 · Cited by 502
The cloche and spadetail Genes Differentially Affect Hematopoiesis and Vasculogenesis
Thompson, M. A., Ransom, D. G., Pratt, S. J., MacLennan, H., Kieran, M. W., Detrich, H. W., Vail, B., Huber, T. L., Paw, B., Brownlie, A. J., et al. (1998) · Developmental Biology · doi:10.1006/dbio.1998.8887 · Cited by 501
Liu, Z.-J., Shirakawa, T., Li, Y., Soma, A., Oka, M., Dotto, G. P., Fairman, R. M., Velazquez, O. C., & Herlyn, M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.1.14-25.2003 · Cited by 500
Oh, S.-J., Jeltsch, M. M., Birkenhäger, R., McCarthy, J. E. G., Weich, H. A., Christ, B., Alitalo, K., & Wilting, J. (1997) · Developmental Biology · doi:10.1006/dbio.1997.8639 · Cited by 498
Self-citationPathological angiogenesis: mechanisms and therapeutic strategies
Dudley, A. C., & Griffioen, A. W. (2023) · Angiogenesis · doi:10.1007/s10456-023-09876-7 · Cited by 495
Vermeulen, P. B., Gasparini, G., Fox, S. B., Colpaert, C., Marson, L. P., Gion, M., Beliën, J. A. M., de Waal, R. M. W., Van Marck, E., Magnani, E., et al. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00094-1 · Cited by 488
Molecular characterization of lymphatic endothelial cells
Podgrabinska, S., Braun, P., Velasco, P., Kloos, B., Pepper, M. S., Jackson, D. G., & Skobe, M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242401399 · Cited by 483
Heterogeneity of Endothelial Cells: Specific Markers
Garlanda, C., & Dejana, E. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.7.1193 · Cited by 483
(2000) · PubMed · Cited by 475
Lymphatic vasculature development
Oliver, G. (2004) · Nature Reviews Immunology · doi:10.1038/nri1258 · Cited by 461
Tumor and its microenvironment: A synergistic interplay
Catalano, V., Turdo, A., Di Franco, S., Dieli, F., Todaro, M., & Stassi, G. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.08.007 · Cited by 444
Vascular Growth Factors and Lymphangiogenesis
Jussila, L., & Alitalo, K. (2002) · Physiological Reviews · doi:10.1152/physrev.00005.2002 · Cited by 443
Self-citationVascular Endothelial Growth Factor Signaling in Hypoxia and Inflammation
Ramakrishnan, S., Anand, V., & Roy, S. (2014) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-014-9531-7 · Cited by 442
Hirakawa, S., Hong, Y.-K., Harvey, N., Schacht, V., Matsuda, K., Libermann, T., & Detmar, M. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63851-5 · Cited by 439
Insights into the mechanisms of lymph node metastasis
Nathanson, S. D. (2003) · Cancer · doi:10.1002/cncr.11464 · Cited by 433
Congenital Hereditary Lymphedema Caused by a Mutation That Inactivates VEGFR3 Tyrosine Kinase
Irrthum, A., Karkkainen, M. J., Devriendt, K., Alitalo, K., & Vikkula, M. (2000) · The American Journal of Human Genetics · doi:10.1086/303019 · Cited by 430
Self-citationVascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis
Karkkainen, M. J., & Petrova, T. V. (2000) · Oncogene · doi:10.1038/sj.onc.1203855 · Cited by 427
Regulation of Blood and Lymphatic Vascular Separation by Signaling Proteins SLP-76 and Syk
Abtahian, F., Guerriero, A., Sebzda, E., Lu, M.-M., Zhou, R., Mocsai, A., Myers, E. E., Huang, B., Jackson, D. G., Ferrari, V. A., et al. (2003) · Science · doi:10.1126/science.1079477 · Cited by 421
The role of VEGF receptors in angiogenesis; complex partnerships
Cébe-Suarez, S., Zehnder-Fjällman, A., & Ballmer-Hofer, K. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5426-3 · Cited by 405
Axon Guidance Molecules in Vascular Patterning
Adams, R. H., & Eichmann, A. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001875 · Cited by 405
Bunone, G., Vigneri, P., Mariani, L., Butó, S., Collini, P., Pilotti, S., Pierotti, M. A., & Bongarzone, I. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65515-0 · Cited by 404
Lee, J., Gray, A., Yuan, J., Luoh, S. M., Avraham, H., & Wood, W. I. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.5.1988 · Cited by 401
Ristimäki, A., Narko, K., Enholm, B., Joukov, V., & Alitalo, K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.14.8413 · Cited by 400
Self-citationVascular Endothelial Growth Factor Receptor-3 in Lymphangiogenesis in Wound Healing
Paavonen, K., Puolakkainen, P., Jussila, L., Jahkola, T., & Alitalo, K. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65021-3 · Cited by 398
Self-citationLymphatic vascular morphogenesis in development, physiology, and disease
Schulte-Merker, S., Sabine, A., & Petrova, T. V. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201012094 · Cited by 394
Saharinen, P., Tammela, T., Karkkainen, M. J., & Alitalo, K. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.05.003 · Cited by 391
Self-citationSkobe, M., Hamberg, L. M., Hawighorst, T., Schirner, M., Wolf, G. L., Alitalo, K., & Detmar, M. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61765-8 · Cited by 388
Self-citationInteraction of tumor cells and lymphatic vessels in cancer progression
Alitalo, A., & Detmar, M. (2012) · Oncogene · doi:10.1038/onc.2011.602 · Cited by 383
VEGFR-3 and CD133 identify a population of CD34+ lymphatic/vascular endothelial precursor cells
Salven, P., Mustjoki, S., Alitalo, R., Alitalo, K., & Rafii, S. (2003) · Blood · doi:10.1182/blood-2002-03-0755 · Cited by 377
Self-citationThe NuRD component Mbd3 is required for pluripotency of embryonic stem cells
Kaji, K., Caballero, I. M., MacLeod, R., Nichols, J., Wilson, V. A., & Hendrich, B. (2006) · Nature Cell Biology · doi:10.1038/ncb1372 · Cited by 375
Oliver, G., & Detmar, M. (2002) · Genes & Development · doi:10.1101/gad.975002 · Cited by 375
Albuquerque, R. J. C., Hayashi, T., Cho, W. G., Kleinman, M. E., Dridi, S., Takeda, A., Baffi, J. Z., Yamada, K., Kaneko, H., Green, M. G., et al. (2009) · Nature Medicine · doi:10.1038/nm.2018 · Cited by 357
Molecular Biology and Pathology of Lymphangiogenesis
Karpanen, T., & Alitalo, K. (2008) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.3.121806.151515 · Cited by 356
Self-citationPartanen, T. A., Arola, J., Saaristo, A., Jussila, L., Ora, A., Miettinen, M., Stacker, S. A., Achen, M. G., & Alitalo, K. (2000) · The FASEB Journal · doi:10.1096/fj.99-1049com · Cited by 346
Self-citationWitzenbichler, B., Asahara, T., Murohara, T., Silver, M., Spyridopoulos, I., Magner, M., Principe, N., Kearney, M., Hu, J.-S., & Isner, J. M. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65582-4 · Cited by 346
Lymphatic Vessel Network Structure and Physiology
Breslin, J. W., Yang, Y., Scallan, J. P., Sweat, R. S., Adderley, S. P., & Murfee, W. L. (2018) · Comprehensive Physiology · doi:10.1002/cphy.c180015 · Cited by 341
Tissue specific regulation of VEGF expression during bone development requires Cbfa1/Runx2
Zelzer, E., Glotzer, D. J., Hartmann, C., Thomas, D., Fukai, N., Soker, S., & Olsen, B. R. (2001) · Mechanisms of Development · doi:10.1016/s0925-4773(01)00428-2 · Cited by 339
Ohta, Y., Shridhar, V, Bright, R. K., Kalemkerian, G. P., Du, W., Carbone, M., Watanabe, Y., & Pass, H. I. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690650 · Cited by 335
Vascular Endothelial Growth Factors VEGF-B and VEGF-C Are Expressed in Human Tumors
Salven, P., Lymboussaki, A., Heikkilä, P., Jääskela-Saari, H., Enholm, B., Aase, K., von Euler, G., Eriksson, U., Alitalo, K., & Joensuu, H. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65550-2 · Cited by 328
Self-citationStacker, S. A., Stenvers, K., Caesar, C., Vitali, A., Domagala, T., Nice, E., Roufail, S., Simpson, R. J., Moritz, R., Karpanen, T., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32127 · Cited by 327
Self-citationLymphangiogenic factors, mechanisms, and applications
Zheng, W., Aspelund, A., & Alitalo, K. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71603 · Cited by 322
Self-citationVEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling
Tammela, T., Zarkada, G., Nurmi, H., Jakobsson, L., Heinolainen, K., Tvorogov, D., Zheng, W., Franco, C. A., Murtomäki, A., Aranda, E., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2331 · Cited by 321
Self-citationSchmidt-Erfurth, U., Schlo¨tzer-Schrehard, U., Cursiefen, C., Michels, S., Beckendorf, A., & Naumann, G. O. H. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-1115 · Cited by 317
Metadata
- Authors
- Kaipainen, A., Korhonen, J., Mustonen, T., van Hinsbergh, V. W., Fang, G. H., Dumont, D., Breitman, M., & Alitalo, K.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1995-04-11
- Volume
- 92
- Issue
- 8
- Pages
- 3566-3570
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2025173623
- Cited by
- 1,423
- References
- 26
- FWCI
- 9.13
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.